What is debridement, antibiotics, and implant retention in orthopaedic oncology?
The study highlights global inconsistencies in DAIR practices for PJI in orthopaedic oncology, with financial disparities impacting modular component exchange. Standardized definitions are lacking, and we propose that if only polyethylene is changed, then the procedure is referred to as 'poly exchange'; we recommend defining the procedure as DAIR when extensive debridement, lavage, and removal, wash, and reimplanting of all modular components is done while retaining stable stems, followed by suppressive antibiotic therapy; and finally, we recommend that if all the modular components are changed for new ones, the procedure is referred to as 'DAIR plus'.
Authors
- Santiago A. Lozano‐Calderón (ORCID: https://orcid.org/0000-0002-0681-9004)
- Lee Jeys (ORCID: https://orcid.org/0000-0002-9005-279X)
- Vineet Kurisunkal (ORCID: https://orcid.org/0000-0001-6923-8947)
- Minna Laitinen (ORCID: https://orcid.org/0000-0002-9975-0121)
- Ashish Gulia (ORCID: https://orcid.org/0000-0002-5133-7442)
- Zainab Aqeel Khan (ORCID: https://orcid.org/0000-0003-1593-0318)
- Zeeshan Khan
- Tomas Zamorra
Institutions
- Khyber Medical College (PK)
- Pontificia Universidad Católica de Chile (CL)
- Bhabha Hospital (IN)
- Helsinki University Hospital (FI)
- Royal Orthopaedic Hospital (GB)
- Massachusetts General Hospital (US)
- Cancer Hospital and Research Institute (IN)
- Pharmo Institute (NL)
Publication Details
- Journal
- Bone & Joint Open
- Published
- 2025-11-20
- DOI
- https://doi.org/10.1302/2633-1462.611.bjo-2025-0114.r2
- Citations
- 1
- Primary Topic
- Management of metastatic bone disease
- Type
- article
- Field-Weighted Citation Impact
- 2.01